Selexis SA hires new strategic partners to strengthen its cell line development services

Selexis SA announced on 11 April that “it has made key strategic hires, signed its one hundredth commercial license agreement (CLA) and purchased and installed million in new laboratory equipment following its acquisition by JSR Corporation in June 2017. Specifically, the company hired new employees, to be based in Geneva, the U.S. and Tokyo, in the areas of whole genome sequencing, global business development, production and operations. The state-of-the-art laboratory equipment will be housed at the company’s laboratory facility and corporate headquarters, which opened last spring in the heart of Geneva’s biotechnology hub, and will allow Selexis to serve its growing partner base.”

Read the full press release